Kaplan–Meier analysis revealed significantly reduced relapse-free survival (RFS) (p < 0.05) in 373 patients with ERα positive breast cancer with high NgBR expression in tumors as compared to 382 patients with low NgBR expression in tumors. The gene discussed is NUS1; the disease is breast carcinoma.